MCLENA-1: A phase ii clinical trial for the assessment of safety, tolerability, and efficacy of lenalidomide in patients with mild cognitive impairment due to alzheimer’s disease
Boris Decourt, Jeffrey Wilson, Aaron Ritter, Christopher Dardis, Frank P. Difilippo, Xiaowei Zhuang, Dietmar Cordes, Garam Lee, Nadia D. Fulkerson, Tessa St Rose, Katurah Hartley, Marwan N. Sabbagh
Dive into the research topics of 'MCLENA-1: A phase ii clinical trial for the assessment of safety, tolerability, and efficacy of lenalidomide in patients with mild cognitive impairment due to alzheimer’s disease'. Together they form a unique fingerprint.